Clinical Trial

Toric Performance And Constant Evaluation

Study acronym: PACE
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The main purpose of this investigation is to support safety and performance assessment of the investigational device with a focus on optimizing the IOL constants based on refractive outcomes.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-23
Trial Details
NCT Number NCT07471295
Lead Sponsor Carl Zeiss Meditec AG
Collaborators: targomedGmbH
Conditions Cataract
Enrollment 130 participants
Start Date 2026-07-13
Primary Completion 2028-02-28 (estimated)
Study Completion 2028-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-22